Stocks in Focus on August 4: Devyani International IPO, Bharti Airtel, Tata Consumers, Adani Enterprises to Kalpataru Power; here are the 5 Newsmakers of the Day

Stocks that are likely to remain in focus today include Kalpataru Power, TCI, Everest Industries, Dhampur Sugar and Bharti Airtel. Source: PTI

At the stock markets, the Sensex at the Bombay Stock Exchange shot up 872.73 points, or 1.65 per cent, to end at an all-time high of 53,823.36, on Tuesday, August 3, 2021. The Nifty 50 spurted 245.60 points, or 1.55 per cent, to a record high of 16,130.75. But certain stocks came in the news after the market was closed. These stocks can impact the indices when it reopens on Wednesday, August 4, 2021. List of such five stocks:

4 IPO’s: Devyani International + Krsnaa Diagnostic + Windlas Biotech + Exxaro Tiles

Devyani International IPO: The initial public offering (IPO) of Devyani International, the operator of fast-food majors Pizza Hut, KFC and Costa Coffee in India, will open for subscription today, i.e., on Wednesday, August 4, 2021, at a price band of Rs 86-90 per share. The offer will be available till Friday, August 6, 2021. Devyani International aims to raise Rs 1,838 crore with the help of a fresh issue of equity shares worth Rs 440 crore and an offer-for-sale (OFS) of up to 155,333,330 equity shares worth Rs 1,398 crore by the promoter and existing shareholder. Besides, the operator of the fast-food chain has raised Rs 825 crore through the anchor book launched on Tuesday, August 3, 2021, a day before the opening of the public issue. The anchor investors include names like Abu Dhabi (4.05%), Aditya Birla Sun Life (4.06%), Ashoka India (4.05%), Goldman Sachs (4.05%), Government of Singapore among others.

TRENDING NOW

See Zee Business Live TV Streaming Below:

Krsnaa Diagnostic Limited: The initial public offering (IPO) of Krsnaa Diagnostics Ltd, one of the fastest-growing diagnostic chains in India, will open for subscription today, i.e., on Wednesday, August 4, 2021, at a price band of Rs 933-954 per share. The offer will be available till Friday, August 6, 2021. The company is planning to raise Rs 1,213 crore from the IPO that comprises of fresh issue of Rs 400 crore and an offer for sale of 85.25 lakh shares aggregating up to Rs 813 crore. Besides, the diagnostic chain operator has raised Rs 537 crore through the anchor book launched on Tuesday, August 3, 2021, a day before the opening of the public issue. The anchor investors include names like ICICI Prudential Pharma Fund (7.26%), Nippon India (7.26%), Nomura (7.26%) and SBI Healthcare (7.26%) among others.

Windlas Biotech: The initial public offering (IPO) of Windlas Biotech, manufacturer of pharmaceutical formulations, will open for subscription today, i.e., on Wednesday, August 4, 2021, at a price band of Rs 448-460 per share. The offer will be available till Friday, August 6, 2021. The company plans to raise Rs 401.53 crore at the upper price band from the IPO that comprises a fresh issue of Rs 165 crore, and an offer for sale of 51,42,067 equity shares by offer for sale. The offer for sale comprises a selling of 11,36,000 equity shares by Vimla Windlass, and 40,06,067 equity shares by Tano India Private Equity Fund II. Besides, the pharmaceutical formulations company has raised Rs 120.4 crore through the anchor book launched on Tuesday, August 3, 2021, a day before the opening of the public issue. The anchor investors include names like ICICI prudential Pharma Fund (20.75%), Nippon India (8.30%), Macquare (8.30%), Optimix (8.30%) among others.

Exxaro Tiles: The initial public offering (IPO) of Exxaro Tiles, a leading manufacturer of vitrified tiles, will open for subscription today, i.e., on Wednesday, August 4, 2021, at a price band of Rs 118-120 per share. The offer will be available for subscription till Friday, August 6, 2021. The Rs 161 crore initial public offer has an issue size is 13.4 million equity shares comprising 11.18 million fresh shares and an offer for sale of up to 2.23 million. Besides, the manufacturer of vitrified tiles has mopped up Rs 23.67 crore through the anchor book launched on Tuesday, August 3, 2021, a day before the opening of the public issue. The anchor investors include names like Quant Mutual Fund-Active Fund (39.44%), Quant Mutual Fund-Quant Small Cap Fund (39.44%) and AG Dynamic (21.12%) among others.

Bharti Airtel + Tata Cosumer + Adani Enterprises

Bharti Airtel: Telecommunications company Airtel has reported a 62.6% quarter-on-quarter decline in the consolidated profit at Rs 283.5 crore for the quarter ended June 30, 2021. It had posted a profit of Rs 759 crore in the previous quarter ended March 31, 2021. Consolidated revenue from operations grew 4.3% QoQ to Rs 26,853 crore as against Rs 25,747 crore posted in the previous quarter. EBITDA grew 4.8% to Rs 12,189 crore in the quarter under review as against Rs 12,583 crore posted in the previous quarter. Telcom has posted a margin of 49.1% in Q1FY22 as against 48.9% posted in Q4FY21. The average revenue per user (ARPU) for the June quarter stood at Rs 146 as compared to Rs 138 in the year-ago period. The company has reported an exceptional gain of Rs 30.5 crore in the quarter as against Rs 440 crore posted in the previous quarter. Highlights:

- Customer Base 32.1 crore v/s 32.1 crore

- Higher tax expenses hurt profit

- India mobile services revenue at Rs 14,306 crore, up 1.6% (QoQ)

- Monthly mobile data consumption per customer at 18.5 GB

- Good Performance from Homes Business and Digital TV segments

- Total CapEx for Q1 at 6,591 crore

- Net Debt-to-EBITDA rises to 3.03x from 2.95x

Tata Consumer: Fast-moving consumer goods company has reported a 42.11% YoY decline in the consolidated profit at Rs 200 crore for the quarter ended June 30, 2021. It had posted a profit of Rs 345.5 crore in the April-June quarter a year ago. Consolidated revenue from operations grew 10.9% to Rs 3,008.5 crore as against Rs 2,713.9 crore posted last year. EBITDA fell 17.2% to Rs 399.5 crore in the quarter under review as against Rs 482.7 crore posted last year. The margins declined to 13.3% in Q1FY22 as against 17.8% posted in Q1FY21. The company has posted an exceptional loss of Rs 3.9 crore on the reported quarter against an exceptional profit of Rs 63.3 crore posted last year. Segmental Performance

India Beverages

- Revenues Up 28.2% to Rs 1267.1 crore v/s Rs 988.6 crore

- EBIT Down 29% to Rs 150.7 crore v/s Rs 212.1 crore

- Margins down to 11.9% v/s 21.5%

- Volume Growth of 3% v/s 4%

India Food

- Revenue Up 19.6% to Rs 704.7 crore v/s Rs 589.1 crore

- EBIT down 16.2% to Rs 96 crore v/s Rs 114.6 crore

- Margins down to 13.6% v/s 19.4%

- Volume growth 17% v/s 8%

International Business

- Revenue Down 12.7% to Rs 767.6 crore v/s Rs 879.2 crore

- Margins down to 12.5% v/s 14.6%

Adani Enterprises: Adani Group’s flagship Adani Enterprises has reported a 9x YoY rise in the consolidated profit at Rs 271 crore for the quarter ended June 30, 2021, as against a profit of Rs 30 crore posted in the same quarter last year. Sequentially, the profit rose 16% as the company posted a profit of Rs 234 crore in the quarter ended March 31, 2021. Consolidated revenue from operations rose 2.4x YoY to Rs 12,579 crore as against Rs 5,265 crore. On a quarter-on-quarter basis, the revenue declined 7% as it posted a revenue of Rs 13,525 crore in the previous quarter. EBITDA grew 2.4x YoY to Rs 796 crore as against Rs 334 crore posted last year. EBITDA dropped 12% QoQ from Rs 904 crore posted in the previous quarter. Margins remained intact at 6.3% on a year-on-year basis, however, the margin dropped to 6.3% from 6.7% on a quarter-on-quarter basis.

Kalpataru Power + TCI + Everest Industries + Dhampur Sugar

Kalpataru Power Transmission Ltd: The global power transmission and infrastructure EPC has reported a 77.7% YoY rise in the consolidated profit at Rs 80 crore for the quarter ended June 30, 2021. It had posted a profit of Rs 45 crore in the same quarter last year. Sales on a consolidated basis, grew 37.5% to Rs 3,204 crore as compared to Rs 2,330 crore posted last year. EBITDA grew 10% YoY to Rs 306 crore as compared to Rs 278 crore posted last year. The margin dropped to 9.5% in Q1FY22 as compared to 11.9% posted in Q1FY21.

Transport Corporation of India: Supply chain management company TCI has reported a 10x YoY rise in the consolidated profit at Rs 47.5 crore for the quarter ended June 30, 2021. It had posted a profit of Rs 4.7 crore in the same quarter last year. Consolidated revenue from operations grew 71% to Rs 696 crore as against Rs 406 crore posted last year. EBITDA rose 144% to Rs 76 crore as against Rs 31 crore posted last year. The margin grew 10.85% in Q1FY22 as against 7.63% posted in Q1FY21.

Everest Industries: The new age building solutions provider has reported a 3% YoY decline in the consolidated profit at Rs 20.3 crore for the quarter ended June 30, 2021. It had posted a profit of Rs 20.9 crore in the same quarter last year. Revenue from operations grew 12% YoY to Rs 355 crore as against Rs 317 crore posted last year. EBITDA fell 9% to Rs 35 crore as against Rs 39 crore posted last year. The margin dropped to 10% in Q1FY22 as against 12% posted in Q1FY21.

Dhampur Sugar Mills: The sugarcane mills company has reported a 20% YoY drop in the consolidated profit at Rs 44 crore for the quarter ended June 30, 2021. It had posted a profit of Rs 55 crore in the same quarter last year. Sales from operations dropped 19.9% YoY to Rs 880 crore as against Rs 1,099 crore posted last year. EBITDA dropped 10.5% to Rs 102 crore from Rs 114 crore posted last year. The margin grew to 11.5% in Q1FY22 from 10.3% posted in Q1FY21.

Dr Reddy’s + Natco Pharma

Dr. Reddy's: Dr. Reddy's announces the re-launch of over-the-counter Naproxen Sodium Tablets USP, 220 mg, the store-brand equivalent of Aleve® in the U.S. Market. Naproxen Sodium Tablets USP, 220 mg, had U.S. retail sales of approximately $316 million as of July 2021 according to IRI*. "The re-launch of Dr. Reddy's Naproxen Sodium Tablets, 220 mg (OTC), is an important addition to our Pain/Analgesics portfolio of OTC products," says Marc Kikuchi, CEO, North America Generics, Dr. Reddy's Laboratories. "
Natco Pharma: Natco Pharma Limited announces that it has transferred the Lenalidomide Capsules ANDA (2.5mg, 5 mg, 10 mg, 15 mg, 20 mg and 25 mg strengths) to Arrow International Limited as per an earlier agreement between the parties. This transfer of the ANDA to Arrow does not materially change any of the terms of the agreement between the parties. Arrow International Limited (an affiliate of Teva Pharmaceutical Industries Ltd) is the marketing partner of NATCO forth is a product in the US market. The ANDA was approved by USFDA in May 2021 with final approval in the 5 mg, 10 mg, 15 mg and 25mg strengths, and tentative approval in the 2.5 mg and 20mg strengths.

J&K Bank + GR Infraprojects

J&K Bank: Market regulator, Securities and exchange board of India (Sebi) has given an exemption to the Jammu &Kashmir government from making an open offer as per the takeover rules while infusing Rs 500 crore through a preferential allotment in the Jammu &Kashmir Bank Ltd. J&K Government is the promoter of the bank. The state government, which currently holds 68.2% in the bank will see its shareholding going up to 74.24%, which means an increase of 6.06%.

GR Infraprojects: G R Infraprojects has received a letter of acceptance for a project worth Rs 364.87 crore from the Bangalore Metro Rail Project.

TAGS: